Galapagos increases share capital through warrant exercises, receives transparency notifications
(Thomson Reuters ONE) -
Mechelen, Belgium; 28 June 2010 - Galapagos NV (Euronext: GLPG) announced today
a ?0.35 million capital increase arising from employee warrant exercises.
Galapagos also announced that it has received transparency notifications from
Apax and Gestion, pursuant to the Belgian transparency legislation (Belgian Act
of 2 May 2007) concerning major holdings in Belgian listed companies.
Share capital increase
Since its inception in 1999, Galapagos has used warrant plans to incentivize
personnel and management and have them share in the success of the company.
Following warrant exercises during the exercise period in June 2010, Galapagos
issued 40,160 new ordinary shares on 28 June 2010 for a total capital increase,
including share premium, of ?349,831.11, or an average of ?8.71 per new share.
No member of the Board or Executive Committee exercised warrants. Following
today's capital increase, Galapagos now has a share capital amounting to
?129,233,772.58, with a total of 23,890,038 ordinary shares outstanding. There
are no other voting securities.
Transparency information
Following on the announcement of a successful private placement on 17 June
2010, Galapagos received a transparency notification on 24 June 2010 that
Altamir Amboise SCA, and Apax Partners SA acting as manager of FCPR Apax France,
sold a combined total of 1,277,366 shares in the Company, reducing their
combined holding to zero shares.
Galapagos received a transparency notification on 28 June 2010 indicating that
Mr. A. Strating, TWE Beheer, TWE Investment, and Gestion Deelnemingen V
currently hold a combined 1,252,550 shares (5.25%); this represents an increase
from the 1,184,692 shares (5.02%) previously notified by Gestion Deelnemingen V.
About Galapagos
Galapagos (Euronext: GLPG; OTC: GLPYY) is a mid-size biotechnology company
specialized in the discovery and development of small molecule and antibody
therapies with novel modes-of-action. The Company is progressing one of the
largest pipelines in biotech, with four clinical and over 50 small molecule
discovery/pre-clinical programs. Through risk/reward-sharing alliances with
GlaxoSmithKline, Eli Lilly, Janssen Pharmaceutica, Merck & Co. and Roche,
Galapagos is eligible to receive up to ?3 billion in downstream milestones, plus
royalties. Together with its BioFocus and Argenta service operations, Galapagos
has over 670 employees and operates facilities in six countries, with global
headquarters in Mechelen, Belgium. More info at: www.glpg.com
CONTACT
Galapagos NV
Onno van de Stolpe, CEO
Tel: +31 6 2909 8028
ir(at)glpg.com
Elizabeth Goodwin, Director Investor Relations
Tel: +31 6 2291 6240
ir(at)glpg.com
This release may contain forward-looking statements, including, without
limitation, statements containing the words "believes," "anticipates,"
"expects," "intends," "plans," "seeks," "estimates," "may," "will," "could,"
"stands to," and "continues," as well as similar expressions. Such
forward-looking statements may involve known and unknown risks, uncertainties
and other factors which might cause the actual results, financial condition,
performance or achievements of Galapagos, or industry results, to be materially
different from any historic or future results, financial conditions, performance
or achievements expressed or implied by such forward-looking statements. Given
these uncertainties, the reader is advised not to place any undue reliance on
such forward-looking statements. These forward-looking statements speak only as
of the date of publication of this document. Galapagos expressly disclaims any
obligation to update any such forward-looking statements in this document to
reflect any change in its expectations with regard thereto or any change in
events, conditions or circumstances on which any such statement is based, unless
required by law or regulation.
[HUG#1427856]
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Galapagos NV via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 28.06.2010 - 18:01 Uhr
Sprache: Deutsch
News-ID 23132
Anzahl Zeichen: 0
contact information:
Town:
Mechelen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 286 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Galapagos increases share capital through warrant exercises, receives transparency notifications"
steht unter der journalistisch-redaktionellen Verantwortung von
Galapagos NV (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
